In selected patients with early stage breast cancer, accelerated partial breast irradiation (APBI) has emerged as an alternative treatment option to whole breast irradiation. The authors of this article review the available modalities, patient selection criteria and consensus guideline recommendations, and current controversies in APBI, and discuss why it has become an accepted therapy for suitably selected patients outside of clinical trials.
- John A. Cox
- Todd A. Swanson
